Lupin gets tentative USFDA approval for Pregabalin; stk up

MUMBAI – Lupin’s subsidiary Lupin Pharmaceuticals Inc has received tentative ANDA approval for its Pregabalin capsules from the USFDA. The drug is used for treatment of neuropathic pain associated with diabetic peripheral neuropathy and other ailments.

The stock was at Rs 463, up 2.85 per cent on the NSE. It touched a high of Rs 463 and low of Rs 452.10 in trade so far.